Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Despite its novel oral formulation, it is still highly unstable in GI fluids and must therefore be consumed in much higher daily doses
PMC 6599858
Your prescriber may later adjust the dose depending on blood sugar response and side effects
Rarely, complications such as infection or color changes in the skin may occur
November 21 Product: Jazz and Zymeworks Ziihera Indication: HER2-positive biliary tract cancer With the FDAs approval of Ziihera on Thursday, Jazz Pharmaceuticals and Zymeworks will go toe-to-toe with AstraZeneca and Daiichi Sankyo, whose antibody-drug conjugate Enhertu (fam-trastuzumab deruxtecan-nxki) was given a broad tumor-agnostic approval in April 2024
US$ 23.65
US$ 27.69
US$ 21.84
US$ 20.58
US$ 21.31
US$ 25.34
![Gardevoir & Sylveon GX (204/214) [Sun & Moon: Unbroken Bonds] Artifact](https://cdn.shopify.com/s/files/1/0266/9513/9533/products/5612c817-132e-4425-bd22-5d7651d4af2d.png?v=1696309874)
